Streetbeat News

Earnings

CYRX

CryoPort projects its FY24 revenue to be in the range of $242M-$252M, which is below the estimated $253.22M.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:14 pm

CYRX

CryoPort reported Q4 2023 earnings with a GAAP EPS of $(1.31), significantly missing the $(0.30) estimate. Sales were $57.260M, also missing the $58.396M estimate, marking a 5.13% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:13 pm

BTMD

Biote (NASDAQ:BTMD) reported Q4 2023 earnings of $0.18 per share, surpassing the $0.08 estimate, but its sales of $45.703M slightly missed the $45.740M estimate. Year-over-year, earnings remained stable while sales grew by 2.74%.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:13 pm

LDI

loanDepot reported Q4 2023 adjusted EPS of $(0.08), missing the $(0.07) estimate, with sales of $228.626M also missing the $236.757M estimate. This represents a 34.76% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:12 pm

SKIN

The Beauty Health Company (SKIN) projects Q1 revenue to be between $77M-$83M, below the estimated $85.53M, and anticipates flat to low-single digit percentage growth for FY24. The company expects a seasonally low Q1 due to increased sales and marketing investments, with an adjusted EBITDA of ($6)-($9) million for Q1 and over $40 million for FY24, assuming stable market conditions and excluding unforeseen events or transactions.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:12 pm

SKIN

Beauty Health (NASDAQ:SKIN) reported Q4 losses of $(0.07) per share, aligning with analyst estimates, and sales of $96.80M, surpassing the $87.63M estimate. This represents a 240% decrease in earnings and a 1.36% decrease in sales from the previous year.

Portfolio Pulse from Happy Mohamed

March 12, 2024 | 8:10 pm

WEST

Westrock Coffee has reaffirmed its 2024 consolidated adjusted EBITDA forecast to be between $60M-$80M, a projection initially disclosed on February 15, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:10 pm

IGIC

Intl General Insurance (IGIC) reported Q4 2023 earnings of $0.65 per share, surpassing the consensus estimate of $0.62 by 4.84%. Gross written premiums for the quarter were $164.9M.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:10 pm

ICAD

icad (NASDAQ:ICAD) reported Q4 earnings with an EPS of $-0.02, beating estimates by 60% but with a revenue decrease of $1.75 million year-over-year. Despite beating last quarter's EPS estimate, the share price dropped by 7% the following day. The company has shown mixed past performance in terms of EPS and revenue against estimates.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 8:10 pm

SURG

Surgepays (NASDAQ:SURG) reported Q4 earnings with an EPS of $0.19, missing estimates by -54.0% against an expected $0.41. Revenue decreased by $3.91 million from the same period last year. Previously, the company had beaten EPS estimates in Q3 2023 but saw a 3.0% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 8:10 pm